[Dynamic mutations of the human genome and their impact on neurologic disease]

Involvement of autoantibodies against G protein-coupled receptors in post-COVID condition and Chronic Fatigue Syndrome.

Scientific reports·2026

Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations.

Frontiers in psychology·2024

Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome.

Journal of translational medicine·2023

Epidemiology of ataxia and hereditary spastic paraplegia in Spain: A cross-sectional study.

Neurologia·2023

Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

Journal of translational medicine·2022

Patient-specific iPSC-derived cellular models of LGMDR1.

Stem cell research·2021

Temporal trends in motor neuron disease mortality in Spain (2000-2024): Population ageing versus generational risk factors.

Medicina clinica·2026

Feasibility and characteristics of contrast-enhanced lung ultrasound in the diagnosis of pulmonary embolism in hospitalized patients.

Medicina clinica·2026

Secukinumab in moderate to severe hidradenitis suppurativa: effectiveness and safety in real-world clinical practice.

Medicina clinica·2026

Tularemia: a re-emerging zoonosis.

Medicina clinica·2026

Complex regional pain syndrome and amputation.

Medicina clinica·2026

Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis.

Medicina clinica·2026

Guillain-Barré Syndrome Revealing Coexisting Cervical Spondylotic Myelopathy: A Diagnostic Pitfall.

Cureus·2026

Pan-Neurofascin Antibody-Associated Nodopathy: A Critical Guillain-Barré Syndrome Mimic in the Differential Diagnosis-Report of Two Cases.

Case reports in critical care·2026

Pathophysiology and biomaterials based therapeutic strategies for spinal muscular atrophy.

In vitro models·2026

Clinical trials in non-ambulatory people with progressive multiple sclerosis: can the nine hole peg test step up as primary outcome measure?

Journal of neurology·2026

TBK1 overexpression reduces neuronal loss in the P497S UBQLN2 mouse model of ALS/FTD.

Neurobiology of disease·2026

Translational dysregulation as a mechanistic driver of cognitive, behavioral, and affective phenotypes in FXS and TSC.

Neuroscience and biobehavioral reviews·2026

Related Experiment Videos

[Dynamic mutations of the human genome and their impact on neurologic disease]

Related Concept Videos

Involvement of autoantibodies against G protein-coupled receptors in post-COVID condition and Chronic Fatigue Syndrome.

Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations.

Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome.

Epidemiology of ataxia and hereditary spastic paraplegia in Spain: A cross-sectional study.

Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

Patient-specific iPSC-derived cellular models of LGMDR1.

Temporal trends in motor neuron disease mortality in Spain (2000-2024): Population ageing versus generational risk factors.

Feasibility and characteristics of contrast-enhanced lung ultrasound in the diagnosis of pulmonary embolism in hospitalized patients.

Secukinumab in moderate to severe hidradenitis suppurativa: effectiveness and safety in real-world clinical practice.

Tularemia: a re-emerging zoonosis.

Complex regional pain syndrome and amputation.

Comparative efficacy and safety of rosuvastatin versus atorvastatin after acute ischemic stroke or transient ischemic attack: A systematic review and exploratory meta-analysis.

Guillain-Barré Syndrome Revealing Coexisting Cervical Spondylotic Myelopathy: A Diagnostic Pitfall.

Pan-Neurofascin Antibody-Associated Nodopathy: A Critical Guillain-Barré Syndrome Mimic in the Differential Diagnosis-Report of Two Cases.

Pathophysiology and biomaterials based therapeutic strategies for spinal muscular atrophy.

Clinical trials in non-ambulatory people with progressive multiple sclerosis: can the nine hole peg test step up as primary outcome measure?

TBK1 overexpression reduces neuronal loss in the P497S UBQLN2 mouse model of ALS/FTD.

Translational dysregulation as a mechanistic driver of cognitive, behavioral, and affective phenotypes in FXS and TSC.

Related Experiment Videos

[Dynamic mutations of the human genome and their impact on neurologic disease]

Related Concept Videos

Related Articles